Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease

被引：0
|
作者：
A Tsuboi
Y Oka
T Kyo
Y Katayama
O A Elisseeva
M Kawakami
S Nishida
S Morimoto
A Murao
H Nakajima
N Hosen
Y Oji
H Sugiyama
机构：
[1] Osaka University Graduate School of Medicine,Department of Cancer Immunotherapy
[2] Allergy and Reumatic Diseases,Department of Respiratory Medicine
[3] Osaka University Graduate School of Medicine,Department of Hematology
[4] Hiroshima Red Cross Hospital & Atomic Bomb Survivors Hospital,Department of Functional Diagnostic Sciences
[5] Osaka University Graduate School of Medicine,Department of Hematology
[6] Nissay Hospital,Department of Cancer Stem Cell Biology
[7] Osaka University Graduate School of Medicine,undefined
来源：
Leukemia | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1410 / 1413
页数：3
相关论文
共 50 条
  • [1] Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease
    Tsuboi, A.
    Oka, Y.
    Kyo, T.
    Katayama, Y.
    Elisseeva, O. A.
    Kawakami, M.
    Nishida, S.
    Morimoto, S.
    Murao, A.
    Nakajima, H.
    Hosen, N.
    Oji, Y.
    Sugiyama, H.
    LEUKEMIA, 2012, 26 (06) : 1410 - 1413
  • [2] WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia
    Malagola, Michele
    Skert, Crisitina
    Morello, Enrico
    Antoniazzi, Francesca
    Borlenghi, Erika
    Turra, Alessandro
    Pagani, Chiara
    Ribolla, Rossella
    Cancelli, Valeria
    Cattina, Federica
    Alghisi, Elisa
    Bernardi, Simona
    Perucca, Simone
    Di Palma, Andrea
    Ruggeri, Giuseppina
    Rossi, Giuseppe
    Caimi, Luigi
    Russo, Domenico
    BLOOD, 2014, 124 (21)
  • [3] WT1 RNA as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia
    Moore, F. R.
    Yang, F.
    Press, R. D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 872 - 872
  • [4] Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease
    Qin, YaZhen
    Zhu, HongHu
    Jiang, Bin
    Li, JinLan
    Lu, XiJing
    Li, LingDi
    Ruan, GuoRui
    Liu, YanRong
    Chen, ShanShan
    Huang, XiaoJun
    LEUKEMIA RESEARCH, 2009, 33 (03) : 384 - 390
  • [5] WT1 Expression for Monitoring Minimal Residual Disease In Acute Lymphoblastic Leukemia Patients
    Shmunk, Irina
    Koneva, Elena
    Suslova, Tatyana
    Zakharova, Marina
    Korobitsina, Olga
    Korobkin, Alexander
    Burmistrova, Alexandra
    BLOOD, 2010, 116 (21) : 1326 - 1327
  • [6] QUANTITATIVE ASSESSMENT OF WT1 EXPRESSION FOR MONITORING MINIMAL RESIDUAL DISEASE IN ACUTE LEUKEMIA PATIENTS
    Shmunk, I.
    Koneva, E.
    Lyubchenko, M.
    Rusakov, M.
    Kiseleva, M.
    Markova, Y.
    Zalcharova, M.
    Korobitsina, O.
    Korobkin, A.
    Burmistrova, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 10 - 10
  • [7] The Role of Wilms' Tumor Gene (WT1) Expression as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia
    Lazzarotto, Davide
    Candoni, Anna
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [8] Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia
    Zhang, R.
    Yang, J. Y.
    Sun, H. Q.
    Jia, H.
    Liao, J.
    Shi, Y. J.
    Li, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (14) : 2679 - 2688
  • [9] POST REMISSION MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 AND LEUKEMIA ASSOCIATED IMMUNOPHENOTYPE PREDICTS RELAPSE IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS
    Malagola, M.
    Skert, C.
    Borlenghi, E.
    Morello, E.
    Chiarini, M.
    Giustini, V.
    Comini, F.
    Turra, A.
    Cattina, F.
    Cancelli, V.
    Cerqui, E.
    Pagani, C.
    Passi, A.
    Ribolla, R.
    Schieppati, F.
    Brenardi, S.
    Perucca, S.
    Di Palma, A.
    Ruggeri, G.
    Rossi, G.
    Caimi, L.
    Russo, D.
    HAEMATOLOGICA, 2015, 100 : 382 - 382
  • [10] Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels
    Inoue, K
    Ogawa, H
    Yamagami, T
    Soma, T
    Tani, Y
    Tatekawa, T
    Oji, Y
    Tamaki, H
    Kyo, T
    Dohy, H
    Hiraoka, A
    Masaoka, T
    Kishimoto, T
    Sugiyama, H
    BLOOD, 1996, 88 (06) : 2267 - 2278
12345